– ShouTi Inc. announced the close of a $100m Series B financing round.
– The round was led by BVF Partners. Additional new investors include Casdin Capital, Cormorant Asset Management, Janus Henderson Investors, Lilly Asia Ventures, Monashee Capital, Sage Partners, Stork Capital, Surveyor Capital (a Citadel company), TCG X, Terra Magnum Capital Partners, Woodline Partners, and co-founder and strategic partner Schrödinger.
– Existing investors also participated in the financing, including Eight Roads, F-Prime Capital Partners, Qiming Venture Partners, Sequoia Capital China, TF Capital and Wuxi AppTec.

– Centivo, a new health plan for self-funded employers that is anchored around leading providers of value-based care, announced today that it has raised an additional $51 million in funding.
– B Capital Group, a leading global technology investor, and Maverick co-led the round.
– Additional existing investors, including Bain Capital Ventures, Company Ventures, Define Ventures, F-Prime Capital, HarbourVest Partners, Ingleside Investors, Nassau Street Ventures, an AVG fund and various individuals also participated.
– These funds will support Centivo’s rapid growth and expansion amid increased demand from employers for health plans that are structurally built to address employee healthcare affordability.

- Innovusion raised $66m in Series B Plus financing. - The round was led by Guotai Junan International Private Equity Fund (GTJAI) with participation from Shunwei Capital. Existing investors Nio Capital, F-Prime Capital, Eight Roads Ventures, and Temasek also participated in the round. - Innovusion will use the new infusion of capital to increase the production capabilities of its automotive-grade LiDARs, expand their global footprint, and further broaden its research and development efforts to promote the widespread adoption of LiDAR technology across autonomous vehicles, smart infrastructure, and high-speed rail transit systems.

- Innovusion raised $66m in Series B Plus financing. - The round was led by Guotai Junan International Private Equity Fund (GTJAI) with participation from Shunwei Capital. Existing investors Nio Capital, F-Prime Capital, Eight Roads Ventures, and Temasek also participated in the round. - Innovusion will use the new infusion of capital to increase the production capabilities of its automotive-grade LiDARs, expand their global footprint, and further broaden its research and development efforts to promote the widespread adoption of LiDAR technology across autonomous vehicles, smart infrastructure, and high-speed rail transit systems.

– MoEngage, an AI customer engagement platform, announced it has raised $32.5 million in a round led by Multiples Alternate Asset Management, with participation from Eight Roads Ventures, F-Prime Capital, and Matrix Partners.
– The San Francisco-based company says the new capital, which brings its total raised to over $72 million, will be used to support its global growth strategy and strengthen its AI and predictive capabilities.

– SonderMind Inc. from Denver, CO develops behavioral health technology to improve mental health clinical outcomes.
– Company closed $150m Series C financing.
– The round was co-led by new investors Drive Capital and Premji Invest with participation from General Catalyst, Partners Group, Smash Ventures, Kickstart Fund, F-Prime Capital, Founders Circle Capital, Zoma Foundation and FCA Venture Partners.
– The new investment will be used to accelerate the company’s expansion into all 50 states.

– Guros announced the closing of a $5.8m investment round, at a $30m valuation.
– The round was led by F-Prime Capital and Cometa, with participation from Clocktower and Insurify and existing investors as well.
– The funding will be used to strengthen the platform capabilities, further customize APIs for commercial partners, expand into health insurance, and grow internally across technology, product and operations.
– Guros allows consumers to gain control over their insurance policies, regardless if they are a Guros policyholder or not. The Guros wallet provides policyholders the ability to save all of their insurance information in one digital location, and car owners the ability to track taxes, speeding tickets, and driving restrictions free of charge.

– Adela specializes in detection of cancer and other high-morbidity, high-mortality conditions through a routine blood test.
– The company raised $60M in Series A funding.
– The round was led by F-Prime Capital with participation from OrbiMed, Deerfield Management, Decheng Capital and RA Capital Management.
– The company plans to use the advance its technology towards commercialization, with initial applications across the cancer care continuum from early detection to disease monitoring.

– Zus Health, a Jonathan Bush-founded company focused on creating the industry’s first shared development platform backed by a shared data record, announced its launch and the close of a $34M Series A financing led by Andreessen Horowitz. F-Prime Capital, Maverick Ventures, Rock Health, Martin Ventures and Oxeon Investments also participated in the round.
– The funding comes at a time when the forces that have long held healthcare innovation back are teetering. The intersection of information sharing friendly policy in the 21st Century Cures Act; never before seen levels of investment from private equity and venture capital into digital-first healthcare companies; and the catalyst of the pandemic; have, in sum, created a thriving young healthcare movement.

– Whatfix, a “digital adoption” platform that enterprises use to bake user support tools into their software, has raised $90 million in a series D round of funding.
– The company’s latest funding tranche was spearheaded by SoftBank’s Visions Fund 2, with participation from Cisco Investments, Sequoia Capital India, Eight Roads Ventures, F-Prime Capital, and Dragoneer Investment Group.

– Zenflow, Inc. is a South San Francisco, CA-based medical device company developing a minimally invasive treatment for urinary obstruction caused by enlarged prostate, or benign prostatic hyperplasia (BPH).
– Company raised $24m in Series B financing round.
– The round was led by Invus Opportunities with participation from F-Prime Capital, Medical Technology Venture Partners, Golden Seeds, Astia Angels, CloudStone Capital, SV Tech Ventures, and others.
– The new investment will be used to further develop the company’s Spring® System, a minimally invasive treatment option for patients who suffer debilitating symptoms due to enlarged prostate.

– Snapdocs announced that it has raised $150m in Series D funding.
– The new round will accelerate Snapdocs’ vision of building the digital infrastructure that connects lenders, settlement services and borrowers together to digitize mortgage closings at scale.
– Tiger Global led the round with participation from Sequoia, Y Combinator, F-Prime, Maverick, Alkeon, and Wellington Management.
– This brings Snapdocs’ total funding to $260m and increases valuation to over $1.5b.
– Snapdocs enables lenders to connect with all parties and technologies involved in a mortgage transaction to complete the entire closing process online.
– The solution is comprehensive – a networked platform that allows the many participants in a mortgage closing to work together more efficiently and close more deals.

– Innovusion is a worldwide leader in the design and development of image-grade LiDAR (Light Detection and Ranging) systems.
– The company raised $64m in Series B funding.
– The round was led by Temasek, BAI Capital, and Joy Capital.
– Existing investors NIO Capital, Eight Roads Ventures, and F-Prime Capital also participated in the round.
– The funding will be used to increase the production capabilities of its automotive-grade LiDARs, support supply-chain partners for mass production capabilities, and further expand Innovusion’s research and development efforts around advanced LiDAR Technologies.
– Innovusion’s products are widely used across autonomous vehicles, smart cities, high-speed rail transit systems, and have been recognized by clients as a top performer.

– 1upHealth has raised a $25m Series B led by F-Prime Capital.
– Existing investors, Jackson Square Ventures (which led our Series A), Eniac Ventures, and Social Leverage also participated.
– The infusion of capital will help us grow and evolve our FHIR connectivity & compute platform that’s already used by dozens of health plans, providers, app developers, and pharma companies.
– When we started selling for CMS compliance, we only had 15 team members. A year later, we are 70 strong, with dozens of health plans and states using our infrastructure and API platform.
– We’re now supporting 11 million of patients through dozens of health plan and provider customers.
– With this new round of capital, we’re positioned for rapid growth.

– Leyden Labs B.V. from Amsterdam develops a platform that targets commonalities of viral families to protect humanity from known and future viruses.
– Series A €40M round was led by GV (formerly Google Ventures), with participation from F-Prime Capital, Casdin Capital, LLC and Brook Byers.
– The company intends to use the funds to further develop the platform and portfolio of product candidates and to build out the team.

– AppliedVR, a pioneer advancing the next generation of digital medicine, today announced $29m in series A funding, bringing its total funds raised to $35m.
– The round, which includes key investors F-Prime Capital, JAZZ Venture Partners, Sway Ventures, GSR Ventures, Magnetic Ventures and Cedars-Sinai, will fuel the company’s growth as it pursues full FDA approval over the next year.
– AppliedVR provides virtual reality-based treatments aimed at comprehensively treating chronic pain. Combining well-established cognitive behavioral therapies with mindfulness exercises, the company’s EaseVRx solution recently became the first VR prescription therapeutic to receive Breakthrough Device Designation from the FDA for treatment-resistant fibromyalgia and chronic intractable lower back pain.

– Vendr, the SaaS buying platform, today announces a $60m Series A led by Tiger Global Management, with participation from existing investors Craft Ventures, Y Combinator, Sound Ventures, Garage Capital, and F-Prime Capital.
– Launched in 2019, Vendr has now facilitated more than $300m in SaaS purchases across 1,000+ suppliers, for customers like HubSpot, Canva, and The Washington Post.
– By empowering buyers to purchase SaaS with ease, Vendr is building the future of frictionless B2B sales.
– With this latest round of financing, Vendr will double down on product expansion and open international operations to service its growing list of global customers.

– YishengBio announced that it has raised US$130m in Series B funding.
– The round was co-led by Oceanpine and OrbiMed.
– The company’s institutional investors include: OrbiMed, Oceanpine, EightRoad, F-Prime Capital, 3W Capital, Hillhouse Capital, Adjuvant Capital, MSA Capital, AIHC, Epiphron Capital, Superstring Capital, Haitong International, etc.
– The company is engaged in discovering, developing and commercializing innovative biotherapeutics for cancers and infectious diseases using novel PIKA® immunomodulating technology.
– The company operates in China, USA, and Singapore with over 500 employees.
– YSJA™ rabies vaccine is the first alum-free lyophilized rabies vaccine launched in China.

– Equip, a health tech company pioneering a program that virtually delivers evidence-based eating disorder treatment to families at home, today announced it has closed $13m in Series A financing, bringing its total funds raised to date to $17m.
– The Series A round was led by Optum Ventures, with participation from new investor .406 Ventures and existing investor F-Prime Capital, who led the company’s prior Seed round.
– Equip’s mission is to make gold-standard eating disorder treatment accessible to all people through Family-Based Treatment (FBT) – the standard of care which empowers families to help their loved ones through recovery.